CD194/CCR4 Chimeric Monoclonal Antibody
Anti-Human CD194/CCR4 Antibody (BMO5282) is a research-grade recombinant antibody targeting CD194. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
K5-5, CCR4, C-C CKR-4, CD194, CC-CKR-4, CCR-4, C-C chemokine receptor type 4, CMKBR4
UniProt
P51679
Reactivity
Human
Clonality
Monoclonal
Clone
BMO5282
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Chimeric
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Human FXYD domain-containing ion transport regulator 7 (FXYD7)
Recombinant Human FXYD domain-containing ion transport regulator 7 (FXYD7)